Morocco medicine price database

ZARZIO

FILGRASTIM

Public price

1,12 MAD

Active substance

FILGRASTIM

Laboratory

NOVARTIS PHARMA

What is this medicine?

A leukocyte growth factor used to manage neutropenia and mobilize hematopoietic progenitor cells.

Verified summary

FILGRASTIM, SOLUTION INJECTABLE POUR PERFUSION, 30 MU / 0,5 ML, BOITE DE 5 SERINGUES

Common uses

Decreasing the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs,Reducing the time to neutrophil recovery and the duration of fever following induction or consolidation chemotherapy in patients with acute myeloid leukemia (AML),Reducing the duration of neutropenia and neutropenia-related clinical sequelae in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT),Mobilizing autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis,Reducing the incidence and duration of sequelae of severe neutropenia in symptomatic patients with congenital, cyclic, or idiopathic neutropenia,Increasing survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)

Class

leukocyte growth factor

Laboratory

NOVARTIS PHARMA

Hospital price

840,00 MAD

Strength

30 MU / 0,5 ML

Form

SOLUTION INJECTABLE POUR PERFUSION

Presentation

BOITE DE 5 SERINGUES

Commercial status

Non Commercialisé

This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.

Price history

Reference price recorded since 2026-06-01: 1,12 MAD

Available presentations and strengths

Medicines with the same active substance